Your browser doesn't support javascript.
loading
Rindopepimut with Bevacizumab for Patients with Relapsed EGFRvIII-Expressing Glioblastoma (ReACT): Results of a Double-Blind Randomized Phase II Trial.
Reardon, David A; Desjardins, Annick; Vredenburgh, James J; O'Rourke, Donald M; Tran, David D; Fink, Karen L; Nabors, Louis B; Li, Gordon; Bota, Daniela A; Lukas, Rimas V; Ashby, Lynn S; Duic, J Paul; Mrugala, Maciej M; Cruickshank, Scott; Vitale, Laura; He, Yi; Green, Jennifer A; Yellin, Michael J; Turner, Christopher D; Keler, Tibor; Davis, Thomas A; Sampson, John H.
Afiliação
  • Reardon DA; Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Desjardins A; Duke University Medical Center, Durham, North Carolina.
  • Vredenburgh JJ; Saint Francis Hospital and Medical Center, Hartford, Connecticut.
  • O'Rourke DM; University of Pennsylvania, Philadelphia, Pennsylvania.
  • Tran DD; Washington University, St. Louis, Missouri.
  • Fink KL; Baylor Research Institute, Dallas, Texas.
  • Nabors LB; University of Alabama at Birmingham, Birmingham, Alabama.
  • Li G; Stanford University School of Medicine, Stanford, California.
  • Bota DA; UC Irvine Medical Center, Irvine, California.
  • Lukas RV; University of Chicago, Chicago, Illinois.
  • Ashby LS; Barrow Neurological Institute, Phoenix, Arizona.
  • Duic JP; Department of Neurosciences, Winthrop University Hospital, Mineola, New York.
  • Mrugala MM; University of Washington School of Medicine, Seattle, Washington.
  • Cruickshank S; Scott Cruickshank and Associates, Santa Barbara, California.
  • Vitale L; Celldex Therapeutics, Inc., Hampton, New Jersey.
  • He Y; Celldex Therapeutics, Inc., Hampton, New Jersey.
  • Green JA; Celldex Therapeutics, Inc., Hampton, New Jersey.
  • Yellin MJ; Celldex Therapeutics, Inc., Hampton, New Jersey.
  • Turner CD; Celldex Therapeutics, Inc., Hampton, New Jersey.
  • Keler T; Celldex Therapeutics, Inc., Hampton, New Jersey.
  • Davis TA; Celldex Therapeutics, Inc., Hampton, New Jersey.
Clin Cancer Res ; 26(7): 1586-1594, 2020 04 01.
Article em En | MEDLINE | ID: mdl-32034072

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Encefálicas / Glioblastoma Tipo de estudo: Clinical_trials Limite: Humans Idioma: En Revista: Clin Cancer Res Assunto da revista: NEOPLASIAS Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Encefálicas / Glioblastoma Tipo de estudo: Clinical_trials Limite: Humans Idioma: En Revista: Clin Cancer Res Assunto da revista: NEOPLASIAS Ano de publicação: 2020 Tipo de documento: Article